Skip to content
healthcare.dev

PAROXETINE HYDROCHLORIDE

NDC 60505-1317, paroxetine hydrochloride, tablet, film coated, extended release, from Apotex Corp.

Product NDC
60505-1317
Status
Listed
Labeler
Apotex Corp
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA AUTHORIZED GENERIC
Application
NDA020936
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/60505-1317 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PAROXETINE HYDROCHLORIDE HEMIHYDRATE25 mg/1

Pharmacologic classes

Serotonin Reuptake Inhibitor [EPC]; Serotonin Uptake Inhibitors [MoA]

Package NDCNDC-11Package
60505-1317-36050513170330 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (60505-1317-3)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/087ff0d3-1761-47ea-a8c1-7c4cb679af97
  • NADAC price for package 60505131703

    GET /v1/drugs/nadac/60505131703

Use it

Look up 60505-1317 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/60505-1317 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 60505-1317. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.